(Q44870246)

7 December 2017

GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK. (English)

1 reference

7 December 2017

Lili Zhang

1

1 reference

7 December 2017

Mengliu Yang

2

1 reference

7 December 2017

Hong Ren

3

1 reference

7 December 2017

Huaidong Hu

4

1 reference

7 December 2017

Guenther Boden

5

1 reference

7 December 2017

Ling Li

6

1 reference

7 December 2017

Gangyi Yang

7

1 reference

7 December 2017

24 February 2013

1 reference

7 December 2017

1 reference

7 December 2017

33

1 reference

7 December 2017

5

1 reference

7 December 2017

794-804

1 reference

Nonalcoholic fatty liver disease

7 December 2017

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

TNF-R1 signaling: a beautiful pathway

21 January 2018

1 reference

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

21 January 2018

1 reference

Nuclear factor κB up-regulation of CCAAT/enhancer-binding protein β mediates hepatocyte resistance to tumor necrosis factor α toxicity

21 January 2018

1 reference

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

21 January 2018

1 reference

GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy

21 January 2018

1 reference

Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis

21 January 2018

1 reference

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

21 January 2018

1 reference

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

21 January 2018

1 reference

Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells

21 January 2018

1 reference

Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients

21 January 2018

1 reference

The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo

21 January 2018

1 reference

Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids

21 January 2018

1 reference

Effect of short hairpin RNA-mediated adiponectin/Acrp30 down-regulation on insulin signaling and glucose uptake in the 3T3-L1 adipocytes

21 January 2018

1 reference

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

Effects of glucagon-like peptide 1 on the hepatic glucose metabolism

21 January 2018

1 reference

JNK regulation of hepatic manifestations of the metabolic syndrome

21 January 2018

1 reference

The JNK signal transduction pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12120

1 reference

7 December 2017

1 reference